News und Analysen
DGAP-Adhoc: SAP SE: SAP plant höhere Kapitalausschüttung in 2020
DGAP-Adhoc: SAP SE: SAP plant höhere Kapitalausschüttung in 2020
DGAP-Adhoc: SAP SE: SAP to Enhance Capital Return in 2020
DGAP-Adhoc: SAP SE: SAP to Enhance Capital Return in 2020
DGAP-Adhoc: Carl Zeiss Meditec erzielt EBIT-Marge von 18,1% im Geschäftsjahr 2018/19
DGAP-Adhoc: Carl Zeiss Meditec erzielt EBIT-Marge von 18,1% im Geschäftsjahr 2018/19
DGAP-Adhoc: Carl Zeiss Meditec achieves EBIT margin of 18.1% in fiscal year 2018/19
DGAP-Adhoc: Carl Zeiss Meditec achieves EBIT margin of 18.1% in fiscal year 2018/19
DGAP-Adhoc: SAP SE: SAP sets course for the future with next generation leadership team
DGAP-Adhoc: SAP SE: SAP sets course for the future with next generation leadership team
DGAP-Adhoc: SAP SE: Verjüngtes Führungsteam stellt Weichen für die Zukunft
DGAP-Adhoc: SAP SE: Verjüngtes Führungsteam stellt Weichen für die Zukunft
DGAP-Adhoc: SAP SE: SAP Pre-Announces Outstanding Third Quarter Results
DGAP-Adhoc: SAP SE: SAP Pre-Announces Outstanding Third Quarter Results
DGAP-Adhoc: SAP SE: SAP veröffentlicht hervorragende Ergebnisse für das dritte Quartal
DGAP-Adhoc: SAP SE: SAP veröffentlicht hervorragende Ergebnisse für das dritte Quartal
EQS-Adhoc: Infineon Technologies AG: Infineon Technologies AG and Qimonda insolvency administrator reach settlement to bring legal dispute to an end by mutual agreement
EQS-Adhoc: Infineon Technologies AG: Infineon Technologies AG and Qimonda insolvency administrator reach settlement to bring legal dispute to an end by mutual agreement
EQS-News: Carl Zeiss Meditec closes first nine months of 2023/24 with slight decline in revenue
EQS-News: Carl Zeiss Meditec closes first nine months of 2023/24 with slight decline in revenue
EQS-News: Infineon Technologies AG: Slight increase in revenue and earnings in Q3 FY 2024. Further improvement expected in Q4 FY 2024. Full-year forecast well within the previously guided range
EQS-News: Infineon Technologies AG: Slight increase in revenue and earnings in Q3 FY 2024. Further improvement expected in Q4 FY 2024. Full-year forecast well within the previously guided range
EQS-Adhoc: Carl Zeiss Meditec AG: Revenue and EBIT forecast for fiscal year 2023/24 reduced amid slower than expected recovery of equipment business
EQS-Adhoc: Carl Zeiss Meditec AG: Revenue and EBIT forecast for fiscal year 2023/24 reduced amid slower than expected recovery of equipment business
EQS-News: Carl Zeiss Meditec closes first six months 2023/24 with a slight decline in revenue due to currency effects
EQS-News: Carl Zeiss Meditec closes first six months 2023/24 with a slight decline in revenue due to currency effects
EQS-News: Infineon: Solid Q2 FY 2024. Prolonged weak demand in major target markets leads to a lowering of the forecast for the fiscal year. Program to strengthen competitiveness starts.
EQS-News: Infineon: Solid Q2 FY 2024. Prolonged weak demand in major target markets leads to a lowering of the forecast for the fiscal year. Program to strengthen competitiveness starts.
EQS-AGM: Deutsche Telekom AG: Announcement of the Convening of the General Meeting in Bonn on 10.04.2024 according to article 121 AktG (German Stock Companies Act) with the objective of Europe-wide distribution
EQS-AGM: Deutsche Telekom AG: Announcement of the Convening of the General Meeting in Bonn on 10.04.2024 according to article 121 AktG (German Stock Companies Act) with the objective of Europe-wide distribution
EQS-Adhoc: SAP SE: SAP Announces Changes to the Supervisory Board
EQS-Adhoc: SAP SE: SAP Announces Changes to the Supervisory Board
EQS-News: Carl Zeiss Meditec achieves slight revenue growth in first quarter of 2023/24
EQS-News: Carl Zeiss Meditec achieves slight revenue growth in first quarter of 2023/24
EQS-News: Infineon with robust Q1 FY 2024. Market environment outside automotive remains weak. Weaker currency and markets are leading to an adjustment of FY 2024 outlook
EQS-News: Infineon with robust Q1 FY 2024. Market environment outside automotive remains weak. Weaker currency and markets are leading to an adjustment of FY 2024 outlook
EQS-Adhoc: Carl Zeiss Meditec AG agrees to launch share buyback program with volume of up to €150m
EQS-Adhoc: Carl Zeiss Meditec AG agrees to launch share buyback program with volume of up to €150m
EQS-Adhoc: SAP SE: SAP Updates its Ambition 2025 and Announces Transformation Program for 2024
EQS-Adhoc: SAP SE: SAP Updates its Ambition 2025 and Announces Transformation Program for 2024
EQS-News: U.S. FDA Approves the VISUMAX 800 with SMILE pro software from ZEISS
EQS-News: U.S. FDA Approves the VISUMAX 800 with SMILE pro software from ZEISS
EQS-Adhoc: Infineon Technologies AG: Court-appointed expert submits opinion in the Qimonda legal dispute
EQS-Adhoc: Infineon Technologies AG: Court-appointed expert submits opinion in the Qimonda legal dispute
EQS-News: Carl Zeiss Meditec AG announces agreement to acquire Dutch Ophthalmic Research Center (D.O.R.C.)
EQS-News: Carl Zeiss Meditec AG announces agreement to acquire Dutch Ophthalmic Research Center (D.O.R.C.)
EQS-Adhoc: Carl Zeiss Meditec AG announces agreement to acquire D.O.R.C.
EQS-Adhoc: Carl Zeiss Meditec AG announces agreement to acquire D.O.R.C.
EQS-News: Carl Zeiss Meditec increased revenue in fiscal year 2022/23 by around 10 percent
EQS-News: Carl Zeiss Meditec increased revenue in fiscal year 2022/23 by around 10 percent